Nurami Medical For Profit

Nurami is a medical company that uses nanofibers and innovative biomaterials to modernize soft tissue surgical repair. They have developed a proprietary electrospun-based platform technology that enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. Their flagship product, ArtiFascia, is a next-generation dural repair implant that provides watertight closure and fosters dura regeneration. ArtiFascia is the first and only device with a 2-in 1 design that is available in the US market. Nurami aims to become a global leader in internal soft tissue repair, revolutionizing the field with their unique combinations of nanofibers and functional biomaterials. Contact_info: Nurami Medical Ltd. HQ, 36 Ha-Namal St., Haifa, Israel, Phone: +972 74 7408822, Email: info@nurami-medical.com. Nurami Medical Inc., 2436 Emrick Boulevard, Bethlehem, PA 18020, USA, Phone: (610) 596-1556, Email: support@nurami-medical.com.

Investors

Founded Date: 2014-01-01
Last Funding Type: Series B
Headquarters: Nazareth, HaZafon, Israel
Investors Number: 1
Technology: Tissue engineering
Employee Number: 11-50
Industry: Regenerative Medicine
Estimated Revenue: $5.0-25M
Last Funding Date: 2020
Number Of Exists: Venture - Series Unknown
Funding Status: N/A
Investor Type: Company
Investment Stage: N/A
Total Funding: 6653159
Register and Claim Ownership